Barrick Gold Corp vs Sana Biotechnology Inc — how do they compare? Barrick Gold Corp trades at $41.33 (market cap $65.92B), while Sana Biotechnology Inc trades at $3.82 (market cap $1.13B). The key difference: Barrick Gold Corp is far larger — about 58.3× Sana Biotechnology Inc's market cap, and Barrick Gold Corp pays a 1.74% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| B | SANA | |
|---|---|---|
Market Cap | $65.92B | $1.13B |
Sector | Basic Materials | Health |
52-Week High | $52.97 | $5.92 |
52-Week Low | $23.50 | $2.68 |
Enterprise Value | $64.67B | $1.05B |
Dividend Yield | 1.74% | — |
Signals from Pluang's Aura AI — not financial advice
Barrick Mining (B) trades at $41.56, up 1.59% with strong bullish momentum. The stock shows robust fundamentals with a P/E of 10.37, net income margin of 31.6%, and consistent earnings beats. Recent developments include a $1.95 billion settlement with Newmont and plans for a North American gold IPO, driving positive sentiment. Technical indicators show bullish moving averages with support at $40 and resistance at $41.
Outlook remains positive with 66.7% analyst buy ratings and a $49.83 consensus target, offering 20% upside. Key risks include gold price volatility and execution of the IPO. Strong cash flow growth and debt reduction support the bullish case, though investors should monitor commodity price trends and operational execution.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Trailing returns across standard periods
Latest headlines on both assets
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →